Jpmorgan Chase & Co »

Xenon Pharmaceuticals shares owned by Jpmorgan Chase & Co

Quarter-by-quarter ownership of Xenon Pharmaceuticals (XENE) shares owned by Jpmorgan Chase & Co from 13F filings

Historical chart of Jpmorgan Chase & Co investment in Xenon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Xenon Pharmaceuticals held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Xenon Pharmaceuticals by Jpmorgan Chase & Co

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.4M 53k 46.06
2023-09-30 $1.7M 50k 34.16
2023-06-30 $3.0M 79k 38.50
2023-03-31 $1.2M 33k 35.66
2022-12-31 $83k 2.1k 39.84
2022-06-30 $74k 2.4k 30.42
2022-03-31 $194k 6.4k 30.50
2021-12-31 $149k 4.8k 31.30
2021-03-31 $116k 6.5k 17.88
2020-12-31 $1.0k 58 17.24
2020-06-30 $1.2M 96k 12.54
2020-03-31 $568k 50k 11.33
2019-12-31 $768k 59k 13.11
2019-09-30 $190k 21k 8.99
2019-06-30 $332k 34k 9.88
2019-03-31 $980k 96k 10.16
2018-12-31 $1.2M 190k 6.31
2018-09-30 $111k 8.4k 13.17
2017-06-30 $34k 11k 3.14
2017-03-31 $14k 3.6k 3.87
2016-09-30 $14k 1.7k 8.24
2016-06-30 $1.0k 111 9.01